Conversion of the primary bile acids cholic acid (CA) and chenodeoxycholic acid (CDCA) to the secondary bile acids deoxycholic acid (DCA) and lithocholic acid (LCA) is performed by a few species of intestinal bacteria in the genus Clostridium through a multistep biochemical pathway that removes a 7a-hydroxyl group. The rate-determining enzyme in this pathway is bile acid 7a-dehydratase (baiE). In this study, crystal structures of apo-BaiE and its putative product-bound [3-oxo-D 4,6 -lithocholyl-Coenzyme A (CoA)] complex are reported. BaiE is a trimer with a twisted a 1 b barrel fold with similarity to the Nuclear Transport Factor 2 (NTF2) superfamily. Tyr30, Asp35, and His83 form a catalytic triad that is conserved across this family. Site-directed mutagenesis of BaiE from Clostridium scindens VPI 12708 confirm that these residues are essential for catalysis and also the importance of other conserved residues, Tyr54 and Arg146, which are involved in substrate binding and affect catalytic turnover. Steady-state kinetic studies reveal that the BaiE homologs are able to turn over 3-oxo-D 4 -bile acid and CoA-conjugated 3-oxo-D 4 -bile acid substrates with comparable efficiency questioning the role of CoA-conjugation in the bile acid metabolism pathway.
INTRODUCTION
The human gut microbiome is a key aspect of normal physiology and metabolic homeostasis. A large number of normal host functions and disease states have been associated with intestinal microbiota. 1-5 Understanding the interplay between host and microbe is a pivotal challenge since the underlying biochemical events are undefined. Metabolomics studies performed with germ-free and conventional mice have identified metabolites processed by microbes, which can influence human health. 6-8 Among such metabolites, secondary bile acids, deoxycholate (DCA) and lithocholate (LCA), which are synthesized from primary bile acids cholate and chenodeoxycholate, respectively, are associated with an increase in the incidence of cancers of the colon, esophagus, and biliary track as well as cholesterol gallstone disease in some patients. 9-12 Furthermore, recent studies of obesity-associated hepatocellular carcinoma (HCC) in mice, implicated DCA with increased secretion of various inflammatory and tumor promoting factors in the liver. 13 This study showed that blocking DCA production could prevent HCC in obese mice.
Bile acids also act as hormones via activating specific nuclear receptors (FXR, PXR, and vitamin D receptor) and plasma membrane G-protein coupled receptors [TGR-5, sphingosine-1-phosphate receptor 2, muscarinic M (2) receptor] in a physiologically relevant manner. Secondary bile acids are more powerful than primary bile acids as activators of PXR, Vitamin D receptor, and TGR-5 in cell signaling pathways. 14 In humans, unlike rodents, DCA can accumulate to very high levels (>60%) in the bile acid pool as the human liver is unable to hydroxylate DCA at the 7a-position. 15 Therefore, by controlling the composition of the bile acid pool, specific gut bacteria may influence aspects of host physiology and influence pathophysiology. Hence, the microbial enzymes involved in secondary bile acid synthesis are potential drug targets for human disease.
Microbial synthesis of secondary bile acids in the human gut involves a multistep biochemical process that results in the removal of C7-hydroxy group from primary bile acids (Fig. 1) . This pathway, which is split into oxidative and reductive arms, involves a series of enzymes that are encoded by a bile acid inducible (bai) operon. 15 The pathway is initiated by the uptake of primary bile acid via a H 1 -dependent active transporter (BaiG) 16 followed by thioesterification to coenzyme A (CoA) by a CoA-ligase (BaiB). 17 The oxidative arm of the pathway converts bile acid-CoA thioester to 3-oxo7a-hydroxy bile acid-CoA and 3-oxo-D 4 27a-hydroxy bile acid-CoA intermediates by BaiA 18 and BaiCD, 19 respectively. The 7a-hydroxy group is removed from the latter through release of water by bile acid 7a dehydratase, BaiE, yielding a 3-oxo-D 4,6 -bile acid-CoA intermediate. 20 The subsequent three reductive steps catalyzed by yet unidentified enzymes constitute the reductive arm generating the secondary bile acid. Two CoA transferases, BaiF and BaiK, participate in the removal of the CoA moiety, although it remains unclear at which stage in the pathway this occurs. 21 Despite the significant influence of this pathway on human health and disease, limited structural and biochemical information is available for the key microbial enzymes involved. We recently reported the structural and steady-state kinetic characterization of BaiA2 from Clostridium scindens VPI 12708, which represents the first structure-function characterization of enzymes in this pathway. 22 Here we report the structural and biochemical characterization of BaiE homologs from Clostridium sp. a key human gut microbe associated with secondary bile acid synthesis. The 7a-dehydroxylation step catalyzed by BaiE is rate limiting for this pathway and is the only irreversible step that directs the intermediate from the oxidative arm to the reductive arm generating the secondary bile acid. BaiE has less than 30% sequence identity with its nearest structural homolog. The BaiE crystal structure reveals a canonical twisted a 1 b barrel fold that is also observed in the Nuclear Transport Factor 2 (NTF2) family. Structure-guided site directed mutagenesis studies were carried out to identify and differentiate residues involved in substrate binding versus those specifically involved in catalysis. Furthermore, comparison of the cocrystal structure of BaiE from Clostridium hiranonis DSM13275 with the partially bound product [3-oxo-
with apo-structures of BaiE homologs revealed a dramatically different conformation of the loop formed by residues 48-63. This segment forms the roof of the active site pocket and suggests conformational flexibility may be needed for substrate binding. Site-directed mutagenesis of Tyr54 indicated impaired substrate turnover indicating the importance of this loop in catalysis. A mechanism for bile acid dehydratase catalysis is proposed based on structural features and site-directed mutagenesis studies. The insight from these structures should facilitate the design of inhibitors which could modulate levels of secondary bile acids in pathways associated with human health and disease.
MATERIALS AND METHODS

Gene cloning and site-directed mutagenesis
Genes of the BaiE homologs were cloned from the corresponding genomic DNAs of C. scindens VPI12708, C. scindens ATCC35704, C. hylemonae DSM15053, and C. hiranonis DSM13275 by Polymerase Incomplete Primer Extension (PIPE) cloning method. 23,24 C. scindens VPI12708 genomic DNA was isolated from anaerobically grown culture. 25 All other genomic DNAs were obtained from the DSMZ (Braunschweig, Germany). The genes were amplified by polymerase chain reaction (PCR) and cloned into the expression vector, pSpeedET, which also encodes an N-terminal tobacco etch virus (TEV) proteasecleavable expression and purification (MGSDKIHHHHH-HENLYFQ/G). Expression clones for PDB ID: 4L8P, 4LEH, 4L8O, and 4N3V are available from the NIH PSI Materials Repository (http://psimr.asu.edu/MRLinks.html) Site-directed mutants were generated using the QuikChange TM Site-Directed Mutagenesis Kit (Agilent Technologies, La Jolla, CA). The expression vector pSport1-19k containing the baiE sequence was used as a template. 20
Protein expression and purification
Proteins utilized for structure determination and kinetic studies were prepared as described previously. 22 Briefly, recombinant protein was expressed at 378C by induction of the arabinose promoter with L-arabinose (0.13%) for 6 h in a 0.5 L culture and purified by single step Ni-NTA chromatography on a 1.5 mL bed volume. LC-MS and SDS-PAGE analysis were consistent with the 22 kDa predicted molecular mass of the BaiE monomer with an N-terminal expression and purification tag. The oligomeric profile was determined by analytical size exclusion chromatography performed at room temperature on an Agilent HP1100 HPLC system utilizing a Shodex 8 3 300 mm Protein KW-802.5 column in 20 mM Figure 1 Proposed steps involved in synthesis of secondary bile acid in human gut anaerobe, Clostridium sp. The oxidative and reductive arms of the pathway are enclosed within salmon and blue colored boxes, respectively. Enzymes with crystal structures solved using the JCSG pipeline are denoted in blue.
Tris pH 7.5, 200 mM NaCl, 0.5 mM TCEP, and 3 mM NaN 3 . The N-terminal expression and purification tags were not cleaved in this study. Selenomethionine (SeMet) derivatized proteins were utilized for structure determination and native proteins were utilized for kinetic studies and co-crystallization trials.
Synthesis of bile acid substrates and products
CoA-thioesters of bile acids were prepared as described previously. 22 -LCA) 27 were synthesized following published procedures. Commercially obtained chemicals used in the synthesis were utilized without further purification or drying.
Steady-state kinetics
Steady-state kinetic parameters were determined using a Varian Cary 100 Bio UV-Visible spectrophotometer equipped with a thermo-jacketed cuvette holder. The reactions at 258C in 20 mM Tris-HCl pH 7.3 monitored the formation of the product at 297 nm. Reaction rates were investigated under varying substrate concentrations below and above the respective K M values. The initial linear regions of the reaction progress curves were utilized for determining the reaction rates. The data were fitted to the Michaelis-Menten equation by non-linear regression method using the enzyme kinetics module in GraphPad Prism (GraphPad Software, La Jolla, CA). H-NMR spectra were acquired at 3008K on a Bruker Avance instrument equipped with a 1H/13C/15N-TXI cryoprobe operating at 600 MHz with 16 scans and a recycle delay of 2 s employing excitation sculpting to suppress water signal (Hwang and Shaka). Isotope-labeled compounds were purchased from Sigma-Aldrich/Isotec. All reaction samples contained 3-(trimethylsilyl)22,2 0 ,3,3 0 -tetradeuteropropionic acid as an internal standard that was referenced to 0 ppm and 10% D 2 O. The reaction was initiated by adding enzyme to an ice cold solution containing 100 mM substrate prepared in deuterated DMSO. Samples were immediately transferred to the NMR instrument and data collection initiated after temperature equilibration as determined by the stability of the signal.
Substrate binding assay
Purified protein (100 lg) was suspended in 50 lL of reaction mixture containing 25 mM sodium acetate pH 7.5 with 3-[N-morpholino]propanesulfonic acid (MOPS) and bile acid substrate (18,000 dpm). The reaction was incubated for 1 min at 378C in 10K Nanosep centrifugal concentrators (Pall Filtron). The concentrators were centrifuged at 10,000g for 2 min. Samples were washed with an additional 100 lL of reaction buffer and centrifuged again for 2 min. Bound counts and effluents were quantified by liquid scintillation spectrometry. Bound counts were corrected for non-specific binding against assays with heat-denatured protein and background binding to the filter.
Crystallization of BaiE
Selenomethionine derivatized BaiE protein from C. scindens ATCC35704, and C. hiranonis DSM13275 yielded crystals from the JCSG Core Suite (Qiagen Sciences, MD), conditions I-D8 (20% w/v PEG3350, 0.2M sodium sulfate, pH 6.6; space group P3 1 21), and IV-D4 (50% w/v PEG200, 0.1M HEPES pH 7.5; space group P6 3 ), respectively. Standard JCSG protocols were utilized for all crystallization trials 28,29 using a drop volume of 0.2 mL and a 1:1 (vol/vol) ratio of reservoir to protein (18.6 mg/mL, C. scindens ATCC35704 and 20.6 mg/mL C. hiranonis DSM13275) in 20 mM HEPES pH 8.0 solution equilibrated against 100 mL of reservoir solution. The crystals were cryoprotected with addition of 10% 1,2 ethanediol (C. scindens ATCC35704) or 10% glycerol (C. hiranonis DSM13275) before harvesting and flash freezing with liquid nitrogen. Co-crystallization trials involving native preparations of the proteins were performed similarly with addition of 1 mM product, 3-oxo-D -LC-CoA). Partial binding of the product (see below) was observed in only one co-crystal of C. hiranonis DSM13275 (space group R32:h) obtained at a protein concentration of 21 mg/mL from JCSG Core Suite condition I-G5 (10% PEG6000, 0.1M citric acid pH 5.0). This crystal was cryoprotected with 15% 1,2-ethanediol. BaiE from C. hylemonae DSM15053 (8.5 mg/mL) yielded crystals [JCSG Core Suite condition III-E2 (0.01M cobalt chloride, 1.8M ammonium sulfate, 0.1M MES pH 6.5; space group R32:h)], but no ordered binding of the product was observed in the structure. Prior to harvesting, 10% ethanediol was added to the drop.
Structure determination of BaiE
Experimental phases for BaiE homologs from C. scindens and C. hiranonis were generated by multiplewavelength anomalous diffraction (MAD) and singlewavelength anomalous diffraction (SAD) methods, respectively. The X-ray diffraction data were collected at wavelengths corresponding to the peak (k 1 ), inflection (k 2 ), and high-energy remote (k 3 ) wavelengths of selenium for the MAD experiments and at the peak wavelength of selenium for the SAD experiments. The data were collected on beamline 11-1 at Stanford Synchrotron Radiation Lightsource at 100 K with a Rayonix Mar Mosaic MX-325 CCD detector using the Blu-Ice datacollection environment. 30 MOSFLM 31 and SCALA 32 were used for data integrating and scaling. Selenium positions were determined with SHELXD and the phases were refined using autoSHARP, 33 with a mean figure of merit of 0.50-2.9 Å in space group P3 1 21 for C. scindens ATCC 35704 and 0.28-1.6 Å in space group P6 3 for C. hiranonis DSM 13275. Automated model building was performed with ARP/wARP. 34 Data for the crystals grown from the co-crystallization trials were collected on beamline 8.2.2 at the Advanced Light Source with an ADSC Q315 CCD detector at 100 K. The data were reduced with XDS 35 and scaled with XSCALE. 36 The structure of BaiE, C. hiranonis DSM13275 was used as a search model for phasing the native BaiE from C. hylemonae DSM15053 and BaiE from C. hiranonis DSM13275 structures originating from the cocrystallization trials. Model completion and iterative cycles of refinement were performed with COOT 37 and REFMAC 38 from the CCP4 program suite. 39 The TLS refinement protocol included one TLS group per molecule in the asu. Coordinates for 3-oxo-D 4,6 -LC-CoA, polyethylene glycol (PEG) and ethylene glycol were generated using PRODRG. 40 The library files containing the refinement restraints were generated using LIBCHECK within CCP4. The quality of the crystal structure was analyzed using the JCSG Quality Control server (http:// smb.slac.stanford.edu/jcsg/QC). This server verifies: the stereochemical quality of the model using AutoDepInputTool, 41 MolProbity, 42 and Phenix, 43 the agreement between the atomic model and the data using RESOLVE, 44 the protein sequence using CLUSTALW, 45 the ADP distribution using Phenix, and differences in R cryst /R free , expected R free /R cryst , and various other items including atom occupancies, consistency of NCS pairs, ligand interactions and special positions using in-house scripts to analyze refinement log file and PDB header. Data collection, model, and refinement statistics are summarized in Table I -CDC-CoA with expected protonation states were generated using the Molecule Builder of MOE and minimized using the Merck Molecular Force Field 943. Search for potential substrate-binding pockets were performed with the Site Finder module in MOE using the induced-fit protocol, which allows rotatable bonds during refinement of the docked molecules. The top 30 hits were retained for further analysis for relevance to catalysis.
RESULTS AND DISCUSSION
Structure of BaiE, bile acid 7a-dehydratase
The final BaiE structures contained one (C. hiranonis DSM13275 in space group P6 3 and C. hylemonae DSM 15053 in space group R32:h), three (C. scindens ATCC 35704 in space group P3 1 21), and two (C. hiranonis DSM13275 in space group R32:h) monomers in the asymmetric unit with R cryst /R free ranging between 15.1/ 18.1 and 19.4/22.5, consistent with the respective resolutions (Table I ). The apo-structures were superimposed using the Secondary Structure Matching (SSM) function in COOT 46 with pairwise rmsds ranging from 0.71 to 0.94 Å [ Fig. 2(A) ]. The major difference in the structures is in the loop formed by residues 48-63, which is in a significantly distinct conformation in each structure. The electron density for the main chain and side chains is well defined throughout, except for the last two Cterminal residues of C. hiranonis DSM13275 and the last three residues of C. hylemonae DSM15053. In addition only Gly0 of the N-terminal expression and purification tag had clearly interpretable electron density. All models exhibited high-quality geometry with overall clash scores greater than 99th percentile, and Ramachandran plot with greater than 97% residues in favored regions as calculated by MolProbity (v4.02b-509). 47 The hexagonal crystals of BaiE from C. hiranonis DSM13275 diffracted to the highest resolution of 1.60 Å .
The BaiE protomer is a single domain structure bearing the characteristic twisted a 1 b barrel fold of the NTF2-like protein superfamily. 48 The secondary structure elements consist of three a-helices and six b-strands [ Fig. 2(B) ]. The six b-strands that form the antiparallel curved b-sheet are assembled on one side of the monomer with a b2-b1-b6-b5-b4-b3 strand order. The three a-helices flank the other side of the molecule and consist of a 34-residue N-terminal helix, a1, and two a-helices of 5 (a2) and 11 (a3) residues. Inspection of the mainchain B-values indicate that residues 48-63 tend to exhibit the highest values in all structures, suggesting conformational flexibility [ Fig. 2(B) ]. A previously reported homology model of BaiE from C. scindens VPI 12708 15 superposes quite well with the crystal structures with a backbone rmsd of 1.7 Å for the core a 1 b barrel fold; however, as expected notable differences are observed for residues 48-63.
Analytical size exclusion chromatography indicated that all BaiE homologs reported here from trimers in solution. BaiE also assembles as a trimer in the crystal structure [ Fig. 2(C) ]. The asymmetric unit of the C. scindens ATCC35704 BaiE crystal (space group P3 1 2) contains what is assumed to be the biological trimer. Similar trimer assemblies can be generated in the other crystal forms by crystallographic symmetry. The trimer interface primarily involves a1 and strand-swapped interactions between b6 and the C-terminal "strand" of the neighboring monomer that stabilizes the bottom of the trimer, with addition minor contributions from b3, b4. Several key interactions are predicted to stabilize the inter-protomer interactions including an octahedral sixatom coordination of a divalent metal ion at the trimer interface. The metal ion coordinates with three H86-Ne2 atoms from each symmetry-related subunit of the trimer and three water molecules within 2.2 Å . This divalent ion-His coordination at the trimer interface is conserved across all known structures of BaiE homologs. The presence of a divalent metal ion at the subunit interface has been previously reported and considered to stabilize the quaternary assembly. 49 The anomalous difference Fourier 
e R cryst 5 RjjF obs | 2 |F calc jj/R|F obs |, where F calc and F obs are the calculated and observed structure factor amplitudes, respectively. f R free 5 as for R cryst , but for 5% of the total reflections chosen at random and omitted from refinement. g Typically, the number of unique reflections used in refinement is slightly less than the total number that were integrated and scaled. Reflections are excluded due to systematic absences, negative intensities and rounding errors in the resolution limits and cell parameters. electron density maps suggests a mixture of Ni 21 and Zn 21 ions in the trimer interface of BaiE, C. hiranonis DSM13275. The Ni 21 likely originated from the metal affinity column used for purification, whereas Zn 21 was likely acquired during protein production. Neither of these metal ions was present in the purification or crystallization buffers. The peak intensity for Ni 21 in the structure is higher than Zn 21 as it likely that some Zn may have been exchanged with Ni during purification. Based on these observations, we modeled the divalent metal ion at the trimer interface in the final deposited model of BaiE, C. hiranonis DSM13275 as Ni 21 . However, the divalent metal ion in the deposited model of the homolog from C. scindens ATCC35704 is modeled as Zn 21 based on the X-ray fluorescence spectroscopy 50 (data not shown). For the homolog from C. hylemonae DSM15053, X-ray fluorescence data were inconclusive and the divalent metal ion was modeled as Co 21 since the crystallization reagents contained CoCl 2 . Many intersubunit salt bridge interactions are also present at the trimer interface (E4-R6, R6-E11, E21-K24, R32-E89, and E150-R154) in addition to multiple hydrogen bond interactions. Similar trimer interface salt bridges and hydrogen bond interaction are also observed in related structures from this protein family, such as scytalone dehydratase (STD) 48 and LinA. 51 However, to our knowledge, the metal-His interaction at the trimer interface in BaiE is the first such interaction observed in this family.
Analysis using DALI 52 and FATCAT 53 suggest BaiE is similar to members of the NTF2 superfamily [ Fig. 2(D) ] The closest structural homologs are STDs (DALI Z score: 16.8) and LinA (DALI Z score: 16.1). SSM superposition by COOT achieved a core backbone rmsd of 1.5 Å >126 C a atoms for comparison with STD 54 (PDB ID: 3STD), 2.6 Å >110 C a atoms with D 5,3 -ketosteroid isomerase 55 (PDB ID: 1OPY), and 3.2 Å >117 C a atoms with LinA (PDB ID: 3A76). BaiE possesses less than 10% sequence identity with the closest structurally related protein.
Substrate binding site
Analysis of both the monomer and the trimer BaiE structure with the Site Finder module of the Molecular Operating Environment package (MOE; Chemical Computing Group, Montreal, Canada) indicates that the substrate-binding pocket [ Fig. 3(A) ] is the largest surface cavity with a volume of 451 Å 3 as determined by CASTp 56 [ Fig. 3(B) ]. Secondary structure elements a1, b1, and b2 form the mouth, while a3, b3, b4, b5, and b6 form the floor of the binding pocket. Y30 (a1), D35 (a1), and H83 (b3) that were shown to participate in catalysis by site-directed mutagenesis (see below) are indeed located in the substrate binding pocket. Crystal structures of the four BaiE homologs revealed the D35 and H83 side chains interact within a distance of 2.8 Å [Fig. 3(C) ]. However, no interaction is observed between Y30 and the other two catalytic residues. In BaiE, C. hiranonis DSM13275, Y30 interacts (2.8 Å ) with an oxygen atom of a PEG molecule bound in the active site. D106 (b4) and R146 (b6) in the substrate binding pocket are conserved across all the BaiE homologs and interact via a salt bridge (2.8 Å ) that is conserved in all apo-structures of BaiE homologs.
Predicted enzyme:substrate interaction by simulated docking experiments
Docking experiments of the substrate 3-oxo-D 4 -CDCA into the BaiE binding pocket with the ASEDock module of MOE identified a potentially productive binding mode that is consistent with our site-directed mutagenesis experiments [ Fig. 4(A) ]. In this binding mode, the C3-oxo and C7-hydroxyl groups are located 3.1 and 3.6 Å from Y30-Oh and H83-NE2 atoms, respectively. H83-NE2 is 2.7 Å from the 6a-hydrogen compared with 4.5 Å from the 6b-hydrogen. The H83-imidazole is therefore positioned to abstract the 6a hydrogen and protonate the leaving C7-hydroxy group complying with a cis-elimination of water (6aH, 7a-OH). However, previous studies with triply tritiated and singly C 14 labeled cholic acid (6a, 6b, 8b-H 3 , 24-C 14 ) detected a diaxial transelimination of water (6bH, 7a-OH). 57 Further experiments with purified BaiE utilizing 3-oxo-D 4 derivatives of both aand b-muricholic acid (3a,6b,7a-trihydroxy-5b-cholanoic acid) and hyocholic acid (3a,6a,7a-trihydroxy-5b-cholanoic acid) should help resolve the stereochemistry of the 7a-hydroxyl elimination reaction.
Computational calculations with the substrate 3-oxo-D 4 -CDC-CoA predicted probable binding interactions of the CoA moiety in addition to predicting a similar productive binding mode of the bile acid moiety [ Fig. 4(B) ]. The calculation predicted a twisted conformation of CoA where the adenine moiety is involved in a p-p stacking interaction with Y115. In such a conformation, a significant portion of both the pantetheine and AMP moieties of CoA would be exposed to the bulk solvent without any direct interaction with the protein. This scenario has previously been observed in crystal structures of thiolase where the AMP portion projects out of the substrate binding pocket and interacts only with surface residues. 58,59 Thus, it seems that only the bile acid moiety binds in the active site pocket with no space to accommodate the CoA moiety. The CoA moiety likely projects out in the solvent possibly interacting with surface residues. This topology is supported by the co-crystal structure of BaiE with 3-oxo-D 4, 6 -LC-CoA where the bile acid moiety is observed to bind in the active site and the CoA moiety extends into the solvent exhibiting poor electron density, as described below. The co-crystal structure of BaiE with 3-oxo-D 4,6 -LCCoA shows a novel extended pocket that was not predicted by the simulated docking experiments. This extended pocket is generated by the substrate binding sites of two protomers that originate from two different trimer assemblies related by two-fold noncrystallographic symmetry (NCS). A key loop comprising residues 48-63 in the substrate binding site of each protomer forms the extended pocket [black and blue circles in Fig. 5(A) ]. Interestingly, this loop in the co-crystal structure protrudes into the substrate binding site of the protomer related by NCS. This extended conformation is stabilized by hydrogen bond interaction with several residues from the NCS related protomer [ Fig. 5(B) ]. Importantly, the D56 carboxylate hydrogen bonds with the H83 imidazole in the NCS related protomer, which is one of the three catalytic residues. An additional set of hydrogen bonds is observed with loop residues T52, Y54, S55, and G57, and their respective partners in the binding site of the two-fold related protomer: K114 (with T52), Y115 (with Y54), H151 (with Y54), R146 (with S55), E149 (with S55), and Y70 (with G57).
Although the resolution (1.9 Å ) of the structure is reasonably high, the electron density of the ligand is relatively poor compared with the protein. Analysis of the electron density map suggests partial occupancy and a dual conformation of the substrate across the NCS twofold axis [ Fig. 5(C) ]. Attempts at modeling the entire product indicated that the ligand extends from the binding site of one protomer to the binding site of the other protomer with the CoA moiety presumably extending into the solvent. Therefore, the bile acid product was modeled in two different orientations.
As shown in Figure 5 (C) in the top and bottom panels, the bile acid moiety is modeled, respectively, into each half of the electron density maps. Furthermore, the ligand comprising only the bile acid and pantetheine moieties fits well into the unbiased mFo-DFc electron density at relatively low contour level, 11.8 rmsd (0.085 e 2 /Å 3 ) in either orientation. In addition, in either orientation, the C3-oxo of the bile acid is within 2.7 Å from the side-chain hydroxyl of the active site Y30 within the same protomer. Hence, in the final deposited structure, the bile acid product was modeled in two overlapping orientations in each active site.
The 2mFo-DFc electron density map generated after addition of the entire product in either orientation revealed continuous electron density features over bile acid moiety and part of the pantetheine moiety at contour levels ranging from 10.8 rmsd (0.21 e ). However, the AMP, the dimethyl group, and the pyrophosphate linkage regions do not have electron density coverage. Although an additional electron density blob is observed adjacent to the bile acid moiety, attempts at modeling the AMP moiety into this blob shows that the shape is not consistent with that assignment. Therefore, due to difficulty in unequivocal assignment of the ligand arising from partial occupancy and dual binding mode across the NCS two-fold, the ligand is modeled as an unknown ligand (UNL) with a dual conformation. In the UNL, the AMP moiety, pyrophosphate linkage and dimethyl group are omitted. -LC-CoA are shown in Figure 6 . Aromatic and methyl regions (left and right panels, respectively) of the spectra acquired at different time points after the addition of enzyme are shown. During the reaction, the intensities of the substrate peaks decrease with a concomitant appearance of a new set of peaks, as readily observed in Figure 6 , where the intensity of selected substrate peaks at 5.81, 1.17, and 0.59 ppm (marked with dashed lines) decrease as the reaction proceeds. This intensity loss is associated with the appearance of a new set of peaks at 5.71, 1.05, 0.63 ppm (marked with dotted lines) that increase in intensity. The reaction appeared to be almost complete after 2 hours with only minor evidence of substrate peaks remaining. The chemical shifts of the new peaks perfectly match a control spectrum acquired of 3-oxo-D 4, 6 -LC-CoA in the same buffer (compound B in Fig.  6 ) and is observed for all peaks in the spectra and not isolated only to the regions displayed. Close examination of -CDC-CoA) with Y115. The key interaction of the bile acid moiety of the docked CoA-bile acid ester with the active site residues is similar to what is predicted in (A). Carbon atoms of protein residues and product molecule are in gold and green, respectively. H, O, N, P, and S atoms are in gray, red, blue, orange, and olive, respectively. the aromatic region in Figure 6 shows the appearance of two new doublets during the reaction as expected for the methene groups generated by removal of the 7a-hydroxyl group. One doublet is isolated and clearly observed at 6.23 ppm (marked with a dotted line) and the second is observed as part of the overlapped peak at approximately 6.14 ppm. These data confirm that BaiE is converting 3-oxo-D -LCCoA.
Site-directed mutagenesis
Mutation of predicted key catalytic and substrate binding residues of BaiE from C. scindens VPI 12708 provide important insights into their involvement in substrate turnover and binding (Table II) . Y30F, D35N, and H83N mutations completely abolished substrate turnover indicating involvement of these residues in catalysis. However, increased substrate binding is observed for mutants Y30F (5.6-fold) and D35N (3.0-fold) compared with wild type, but no substrate binding is found for the H83N mutant. Y30 of BaiE is equivalent to Y14 in 3-oxo-D 5 -ketosteroid isomerase (KSI) and is predicted to participate as a general acid protonating or forming a low barrier hydrogen bond (LBHB) with the dienolate intermediate during the isomerization reaction. 55 Y126 may stabilize the negative charge on the dienolate intermediate as confirmed by 98% reduced catalytic activity observed in Y126F. In KSI, D99 participates in catalysis in a similar manner. H83 and D35 are equivalent to the H85-D31 catalytic dyad in STD that is predicted to participate as a general base. 60 Mutation of the H85-D31 pair in STD also impaired catalysis. Site-directed mutagenesis also revealed D106 and R146 in the substrate binding pocket as essential for catalysis. In all apostructures of BaiE, side chains of D106 and R146 interact via salt bridge at a distance of 2.9 Å . Disruption of this salt bridge by mutation to Asn and Gln at positions 106 and 146, respectively, abolished catalysis. Site-directed mutagenesis of one residue of the conformationally flexible loop comprising residues 48-63 indicates the importance of this loop in catalysis. A Y54F mutation reduced enzyme activity by 74% compared with wild type, whereas Y54A abolished enzyme activity. This result suggests Y54 is probably important for maintaining the shape of the active site and recognition of the substrate. In the 3-oxo-D 4, 6 -LC-CoA co-crystal structure of BaiE, Y54 seems to be involved in key stacking interactions with Y115 and H151 of the NCS two-fold related monomer at the pocket interface.
Steady state kinetic studies
Steady-state kinetics (Table III) analysis was performed by continuous UV assay monitoring of the formation of product utilizing an extinction coefficient, e 297 5 0.0188/ mM/cm, measured at pH 7.3. All four homologs of BaiE revealed robust turnover of CoA-esters of bile acid and free bile acid substrates. The substrate affinity, K M , for -CDC-CoA are also of comparable magnitude across all homologs except for BaiE C. hiranonis DSM13275 where the K M is 208 mM, which is at most two orders of magnitude higher than the others. Furthermore, the turnover rate constants (k cat ) of both substrates are comparable in all three homologs except C. scindens VPI12708, where the k cat is at most 7.7 times higher. Both BaiE homologs from C. scindens ATCC35704 and VPI12708 respectively exhibited higher substrate specificity (k cat /K M ) toward the CoAester substrate by an order of a magnitude. In contrast, both BaiE homologs from C. hylemonae DSM15053 and C. hiranonis DSM13275, respectively, exhibited k cat /K M values of equal magnitude toward both substrates. Overall, higher k cat /K M values are attained for the BaiE homologs from C. scindens strains in comparison to the homologs from the other two strains.
Mechanism of catalysis
Based on the active site architecture as observed in the crystal structures and the site-directed mutagenesis study, we propose the following mechanism of catalysis by BaiE (Fig. 7) . Y30 acts as a general acid (assisted by Y126) facilitating delocalization of the p-electrons across atoms C3, C4, C5, and C6. Based on the 3-oxo-D 4 -CDC-CoA co-crystal structure, the terminal hydroxyl group of Y30 could potentially protonate the oxyanion generated on C3-oxo group to stabilize the negative charge. This would result in an electron shift destabilizing the C6-6aH bond. H83 is then positioned to abstract the 6aH atom and protonate the leaving C7a-hydroxy group. D35 maintains the pK a value of the H83-imidazole group for executing the deprotonation and ensuing protonation reaction with the subsequent release of a water molecule.
CONCLUSION
Combined structural and biochemical analysis of BaiE provides key insights into substrate binding and turnover. The 1.9 Å resolution 3-oxo-D 4, 6 -LC-CoA co-crystal structure of BaiE revealed an extended pocket between monomers from different trimer assemblies, although the biological relevance of this is unclear. Substrate and cofactor induced oligomerization is previously noted to be involved in catalysis of varied enzyme classes. 58 -61 Moreover, using analytical size exclusion chromatography (AnSEC) on the batch of BaiE C. hiranonis DSM13275 that yielded the co-crystal structure, we were able to detect higher-order species of the protein in presence of both bile acid substrates and products (data not shown). Although we have not been able to directly correlate these higher-order species with enzymatic activity, our data suggest possible substrate and ligand-induced oligomerization where the substrate/product binds in the extended pocket created between trimers by conformational flexibility of residues 48-63, as observed in the crystal structure. Comparison of the apo-structures across varied homologs reveals a dramatically different conformation of loop 48-63. The conformational flexibility of this loop at the substrate binding site may be essential for substrate binding. Site-directed mutagenesis studies with Y54F and Y54A mutants of BaiE from C. hylemonae VPI12708 revealed respective impaired substrate binding and catalytic activity, suggesting the importance of this loop in catalysis.
The biochemical characterization reported herein provides key insights into the mechanism of catalysis of the enzyme, and also sheds new light onto the pathway. Steady-state kinetic studies reveal that all homologues of BaiE efficiently turnover both 3-oxo-D 4 -bile acid and CoA-3-oxo-D 4 -bile acid esters. This result is in stark contrast to our earlier reported characterization of BaiA enzymes that exhibited substantially high substrate specificity toward CoA-bile acid esters. 22 The substrate selectivity of bile acids is substantially lower for BaiA enzymes. It is unclear at what point in the pathway the CoA moiety is released. Since the BaiE homologues turnover bile acid and CoA-bile acid ester with comparable efficiency, it seems likely that a dual possibility exists in the pathway where the CoA moiety can be removed either before or after elimination of the C7-hydroxy group. Strains of human bile acid 7 a/b-dehydroxylating bacteria do not 7-dehydroxylate muricholic acids. This could be due to lack of uptake of muricholic acids (transporter specificity), or ligation to CoA, oxidation of 3-a-hydroxy group, or introduction of a C@C double bond (C4AC5). In other words, the initial reactions in the pathway may not allow the 3-oxo-delata 4-6-b, 7a-dihydroxy-cholenoic acid to be formed. Therefore, it is unclear if the bile acid 7a-dehydratase would recognize this as a substrate. However, muricholic acids are not found in humans and we have been unable to isolate bile acid 7-dehydroxylating bacteria from mice using the same techniques used to successfully isolate these bacteria from human feces. Furthermore, the DNA probes used to detect genes in human isolates give negative results using mice fecal samples. Evaluating the substrate specificity of yet-to-be identified enzymes in the reductive arm of the pathway for CoA-bile acid esters and bile acid is required to understand the role of CoA in the pathway. Site-directed mutagenesis with the homologue from C. scindens VPI12708 provides key insights into substrate binding and catalysis. Y30, D35, and H83, which are conserved in the family, were confirmed as active site residues participating in catalysis. In addition, Y54, D106, and R146 in the active site are crucial in catalysis, although they do not directly participate in the catalytic chemistry.
This study has therefore provided key insights into the mechanism of C7a-hydroxy group removal from the bile acid moiety catalyzed by BaiE. Previous studies alluded to the possibility of trans-elimination as the stereochemical route of the reaction. 57 However, from the crystal structures and simulated docking study, cis-elimination is a likely possibility. Further experiments involving 3-oxo-D 4 intermediate of a-muricholic acid may ascertain the stereochemical route.
The reaction catalyzed by BaiE is pivotal in the pathway as it catalyzes the only irreversible reaction whereby the intermediate is channeled onto the reductive arm generating the secondary bile acids. Hence, the biochemical and the structural characterization of this enzyme will be crucial in generating key modulators controlling the level of secondary bile acids in disease.
